SUCCESS: Series of Unique Creative Continuing Education Self Studies

CME COURSE: Platelet Refractoriness: Patient Evaluation and Product Selection

This course defines platelet refractoriness and describes the relevant antigens. Antigen typing and testing are reviewed. Finally, this educational session concludes with identification of the treatment options including their relative advantages and limitations.   

TARGET AUDIENCE: This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products, care for blood donors or have related interests. There are no participant prerequisites for this activity.

LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:

1. Define platelet refractoriness.
   

2. Compare immune to non-immune platelet refractoriness.
   

3. Summarize the different types of tests used in the evaluation of platelet refractoriness.
   

Formulate a patient evaluation and product selection algorithm which best meets your needs and location.

LEARNING TASKS
To receive CME credit for this course, participants must:

1. Acknowledge your review of the activity prerequisites, objectives, disclosures, methods of physician participation and statements.
   

2. Review the presentation or read the PowerPoint slides and accompanying notes available as a printable Adobe Reader® file.
   

3. Take the online Post-Test.
   

4. Complete the online Course Evaluation.
   

5. Print the certificate awarding awarding 1.0 AMA PRA Category 1 credit(s)^TM through the SUCCESS^TM program.

FACULTY
Randal B. Covin, MD

Medical Director, American Red Cross Blood Services

Pacific Northwest Region

Portland, OR

Logan Happney

HLA Laboratory Technologist II, American Red Cross Blood Services

Carolinas Region

Charlotte, NC

ACTIVITY PLANNER
Liz Marcus
Director, Hospital Sales and Marketing
Biomedical Headquarters American Red Cross
Washington DC

DISCLOSURES
The faculty has indicated that he has no relevant financial relationships with commercial interests to disclose.  No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM ; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 75% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

RELEASE DATE: 01/06/2020

CME CREDITS: 1.0 AMA PRA Category 1 Credit(s)^TM

EXPIRATION DATE: 01/05/2023

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour